Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - TOTAL RECEIVABLES
Total Receivables EXEL - Exelixis, Inc.
237 M
LAST VALUE
-8.35%
2 YEAR CAGR
5.83%
5 YEAR CAGR
50.66%
10 YEAR CAGR